Confirmation of high-throughput screening data and novel mechanistic insights into VDR-xenobiotic interactions by orthogonal assays
(Nature) Scientific Reports | (2018) 8:8883 | DOI:10.1038/s41598-018-27055-3
This study looked at the interaction of many drugs and toxins with the Vitamin D Receptor
Vitamin D Receptor is one of 5 Vitamin D genes invisible to blood test
- Vitamin D Receptor test for 29 dollars – Oct 2016
- Vitamin D Receptor category listing has
494 items along with related searches
(a) VDR agonists: as % increase of D3
Note: Calcipotriol treats Psoriasis - by increasing the D3 getting to cells
Example: Cadmium (toxic) reduces response to just 12% of normal
Debabrata Mahapatra1, Jill A. Franzosa5, Kyle Roell2, Melaine Agnes Kuenemann2, Keith A. Houck 5, David M. Reif 2, Denis Fourches2 & Seth W. Kullman3,4 swkullma at ncsu.edu
1 Comparative Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
2 Department of Chemistry, Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, USA.
3 Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA.
^Program in Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina, USA.
5 National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, RTP, Raleigh, North Carolina, USA.
High throughput screening (HTS) programs have demonstrated that the Vitamin D receptor (VDR) is activated and/or antagonized by a wide range of structurally diverse chemicals. In this study, we examined the Tox21 qHTS data set generated against VDR for reproducibility and concordance and elucidated functional insights into VDR-xenobiotic interactions. Twenty-one potential VDR agonists and 19 VDR antagonists were identified from a subset of >400 compounds with putative VDR activity and examined for VDR functionality utilizing select orthogonal assays. Transient transactivation assay (TT) using a human VDR plasmid and Cyp24 luciferase reporter construct revealed 20/21 active VDR agonists and 18/19 active VDR antagonists. Mammalian-2-hybrid assay (M2H) was then used to evaluate VDR interactions with co-activators and co-regulators. With the exception of a select few compounds, VDR agonists exhibited significant recruitment of co-regulators and co-activators whereas antagonists exhibited considerable attenuation of recruitment by VDR. A unique set of compounds exhibiting synergistic activity in antagonist mode and no activity in agonist mode was identified. Cheminformatics modeling of VDR-ligand interactions were conducted and revealed selective ligand VDR interaction. Overall, data emphasizes the molecular complexity of ligand-mediated interactions with VDR and suggest that VDR transactivation may be a target site of action for diverse xenobiotics.Vitamin D2 and Calcipotriol (psoriasis drug) increase Vitamin D3 getting to cells – June 2018
4445 visitors, last modified 02 Jul, 2018,This page is in the following categories (# of items in each category)
ID Name Comment Uploaded Size Downloads 10072 Antagonists.jpg admin 02 Jul, 2018 16:23 37.01 Kb 628 10071 Improve VDR.jpg admin 02 Jul, 2018 15:19 56.48 Kb 337 10070 Inhibit CYP24A1.jpg admin 02 Jul, 2018 15:19 74.44 Kb 688 10069 VDR and Toxins.pdf PDF 2018 admin 02 Jul, 2018 15:18 1.43 Mb 1159